Related Experiment Video
Updated: May 2, 2026
09:31
Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets
Published on: June 25, 2012
13.4K
Vanin-1 is a key activator for hepatic gluconeogenesis
Siyu Chen1, Wenxiang Zhang1, Chunqi Tang1
1Jiangsu Key Laboratory for Molecular and Medical Biotechnology and College of Life Sciences, Nanjing Normal University, Nanjing, Jiangsu, China.
Diabetes
|February 20, 2014
Summary
Vanin-1 (VNN1) is a liver protein that increases glucose production in the body. This study shows VNN1 plays a key role in hyperglycemia, suggesting it as a potential target for metabolic disease treatments.
Area of Science:
- Metabolic pathways
- Liver function
- Oxidative stress
Background:
- Vanin-1 (VNN1) is a liver-enriched protein linked to metabolic regulation.
- Elevated VNN1 levels are observed in diabetic patients, but its role is unclear.
Purpose of the Study:
- To investigate the physiological role of VNN1 in hepatic gluconeogenesis and its connection to hyperglycemia.
Main Methods:
- Examined hepatic VNN1 expression in fasted and insulin-resistant mice.
- Conducted gain- and loss-of-function studies of VNN1.
- Investigated the Akt signaling pathway and transcriptional regulation by PGC-1α and HNF-4α.
- Performed chromatin immunoprecipitation assays.
Main Results:
- Hepatic VNN1 expression increased in fasted and insulin-resistant mice.
- VNN1 overexpression elevated gluconeogenic gene expression and hepatic glucose output, causing hyperglycemia.
- VNN1's effects on gluconeogenesis are mediated by the Akt pathway.
- PGC-1α and HNF-4α synergistically activate vnn1 transcription.
Conclusions:
- VNN1 plays a significant role in regulating hepatic gluconeogenesis.
- VNN1 may be a therapeutic target for metabolic diseases characterized by excessive gluconeogenesis.
Related Concept Videos
01:05Insulin Secretory Vesicles
6.3K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.3K
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.8K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.8K
01:16Hormones Regulating Blood Glucose
7.5K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
7.5K
01:25Insulin: Biosynthesis, Chemistry, and Preparation
2.1K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
2.1K
01:28Insulin: The Receptor and Signaling Pathways
6.0K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
6.0K
01:24Glucagon-like Receptor Agonists
1.3K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.3K